After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
BCYC belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Bicycle Therapeutics Plc ADR is $411.93M. A total of 0.59 million shares were traded on the day, compared to an average of 273.97K shares.
In the most recent transaction, Lee Kevin sold 3,231 shares of BCYC for 8.41 per share on Oct 03 ’25. After the transaction, the CHIEF EXECUTIVE OFFICER now owns 475,310 company shares. In a previous transaction on Oct 02 ’25, Lee Kevin sold 2,263 shares at 8.40 per share. BCYC shares that CHIEF EXECUTIVE OFFICER owns now total 478,541.
Among the insiders who sold shares, Skynner Michael disposed of 978 shares on Oct 03 ’25 at a per-share price of $8.41. This resulted in the CHIEF TECHNOLOGY OFFICER holding 118,277 shares of BCYC after the transaction. In another insider transaction, Skynner Michael sold 824 shares at $8.40 per share on Oct 02 ’25. Company shares held by the CHIEF TECHNOLOGY OFFICER now total 119,255.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, BCYC has a high of $28.67 and a low of $6.10.
As of this writing, BCYC has an earnings estimate of -$1.08 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of -$0.74 per share and a lower estimate of -$1.27. The company reported an EPS of -$0.72 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. BCYC’s latest balance sheet shows that the firm has $438.68M in Cash & Short Term Investments as of fiscal 2021. There were $44.34M in debt and $36.24M in liabilities at the time. Its Book Value Per Share was $9.66, while its Total Shareholder’s Equity was $346.25M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BCYC is Buy with a score of 4.38.
